A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies
Recruiting · NCT06224855 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 1 | 2026-09-25 | NCT06224855 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hangzhou DAC Biotechnology Co., Ltd. | 6 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Cancer Hospital | Hefei | China | 8 |
| Hunan Cancer Hospital | Changsha | China | 123 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 109 |
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |